ROCKVILLE, Md., March 3 /PRNewswire-FirstCall/ -- Human Genome
Sciences, Inc. (Nasdaq: HGSI) announced today that a panel presentation and
discussion at the Susquehanna Financial Group Second Annual SIGnificant
Investment Options in Healthcare Conference will be webcast and may be
accessed at http://www.hgsi.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )
A senior member of Human Genome Sciences' clinical management team will
participate in a panel presentation and discussion entitled "Potential New
Therapies in SLE" on Wednesday, March 5, 2008.
Investors interested in listening to a replay of this panel discussion
should log on after 6:00 pm on March 5, 2008 to access the audio recording.
The mission of HGS is to apply great science and great medicine to
bring innovative drugs to patients with unmet medical needs.
HGS and Human Genome Sciences are registered trademarks of Human Genome
Sciences, Inc. For additional information on Human Genome Sciences, Inc.,
visit the company's web site at http://www.hgsi.com.
SOURCE Human Genome Sciences, Inc.
 back to top
Related links:
http://www.hgsi.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO
AP Archive: http://photoarchive.ap.org PRN Photo Desk
photodesk@prnewswire.com
http://www.prnewswire.com/comp/121115.html /
CONTACT:
Jerry Parrott, Vice President, Corporate
Communications, +1-301-315-2777, or Kate de Santis, Director,
Investor Relations, +1-301-251-6003, both of Human Genome
Sciences, Inc.
|
